Pharmafile Logo

Behaviour change – is there something missing?

Successful and impactful behaviour change requires commitment and time

- PMLiVE

Meg Morgan, Strategic Solutions Director

There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example. So why is it that some of us ignore the evidence and risk our health? What does it really take to change our thinking, the way we make decisions and how we behave?

While we may think that complex interventions are needed to successfully change behaviours, recent concepts such as Nudge Theory are suggesting otherwise. Nudges are particular types of interventions, the results of which can provide direct insight into a person’s behaviour. For example, providing prescription drugs in different colours to encourage adherence, or painting piano keys on stairs to encourage use instead of the escalator, are immediate impact interventions which have been shown to have a great effect. The impact of nudges can help shape future interventional strategies and therefore can work as part of longer-lasting and larger initiatives.

This is not to suggest that nudges are all it takes to effect a change in behaviour in every case. Bold programmes and interventions that focus on individual needs are shown to have a massive effect too. In 2012 Public Health England launched Stoptober, a national smoking cessation campaign that resulted in a ~50% increase in quitting during October compared with other months in the same year. This showed that designing a campaign with clear behavioural targets and fundamental psychological theory can result in impressive outcomes in an area of health that is notoriously difficult to influence.

So, if we understand our audience better and as a result are able to create highly effective change programmes, have we cracked the code? Probably not.

Trust is another key ingredient. Successful and impactful behaviour change takes understanding, the building of real trust and, because of that, it requires commitment and time. For the pharmaceutical industry this is where our real challenge lies.  Building trust across all operations from research and development, to patient advocacy, to corporate communications means a commitment over time.  The pharmaceutical industry has all the tools and a great opportunity to address this. It already invests hugely in long-term development programmes to understand drug efficacy and safety; the step required to take the same long-term view on implementing behaviour change programmes is not so big. If behavioural aspects are investigated early in the drug life cycle and implemented across all operations and, it will be a real win-win for all involved.

Contact Bedrock Health to talk about the missing link in your behaviour change communication programme.

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock LEAPs to new heights

What do our future leaders say about LEAP?

Bedrock Group strengthens its senior team

Bedrock strengthen its management team with the recruitment of two senior roles

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

The playbook of a 'reluctant creative'

Are we all capable of being creative?